Cost-effectiveness of telehealth for patients with depression: Evidence from the Healthlines randomised controlled trial

BJPsych Open

Volumn 2, Issue 4, 2016, Pages 262-269

  Dixon, Padraig ^b   Hollinghurst, Sandra ^b   Edwards, Louisa ^b   Thomas, Clare ^b   Foster, Alexis ^a   Davies, Ben ^b   Gaunt, Daisy ^b   Montgomery, Alan A ^b,c   Salisbury, Chris ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85019632646     PISSN: None     EISSN: 20564724     Source Type: Journal    
DOI: 10.1192/bjpo.bp.116.002907     Document Type: Article

References (42)

1. Department of Health. Long Term Conditions Compendium of Information. Department of Health, 2012.
2. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) Surveys. Epidemiol Psichiatr Soc 2009; 18: 23-33.
3. Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman ATF. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand 2010; 122: 184-91.
4. Kessler RC. The costs of depression. Psychiatr Clin North Am 2012; 35: 1-14.
5. London School of Economics and Political Science Centre for Economic Performance Mental Health Policy Group. The Depression Report: A New Deal for Depression and Anxiety Disorders. LSE Research Online, 2006.
6. Vassilev I, Rowsell A, Pope C, Kennedy A, O'Cathain A, Salisbury C, et al. Assessing the implementability of telehealth interventions for self-management support: a realist review. Implement Sci 2015; 10: 59.
7. World Health Organization. Glossary of Globalization, Trade and Health Terms. Secondary Glossary of Globalization, Trade and Health Terms (http://www.who.int/trade/glossary/story021/en/).
8. Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry 2007; 29: 388-95.
9. Kendrick T, Dowrick C, McBride A, Howe A, Clarke P, Maisey S, et al. Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ 2009; 338: b750.
10. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med 2001; 16: 606-13.
11. Salisbury C, Thomas C, O'Cathain A, Rogers A, Pope C, Yardley L, et al. TElehealth in CHronic disease: mixed-methods study to develop the TECH conceptual model for intervention design and evaluation. BMJ Open 2015; 5: e006448.
12. Thomas CL, Man M-S, O'Cathain A, Hollinghurst S, Large S, Edwards L, et al. Effectiveness and cost-effectiveness of a telehealth intervention to support the management of long-term conditions: study protocol for two linked randomized controlled trials. Trials 2014; 15: 36.
13. Salisbury C, O'Cathain A, Thomas C, Edwards L, Montgomery AA, Hollinghurst S, et al. Telehealth for patients with long-term health conditions: development and evaluation of the Healthlines Service. NIHR J Libr Programme Grants Appl Res, in press.
14. Salisbury C, O'Cathain A, Edwards L, Thomas C, Gaunt D, Hollinghurst S, et al. Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex intervention. Lancet Psychiatry 2016; 3: 515-25.
15. NICE. Guide to the Methods of Technology Appraisal. 2013.
16. Merriel SW, Andrews V, Salisbury C. Telehealth interventions for primary prevention of cardiovascular disease: a systematic review and meta-analysis. Prev Med 2014; 64: 88-95.
17. Segar J, Rogers A, Salisbury C, Thomas C. Roles and identities in transition: boundaries of work and inter-professional relationships at the interface between telehealth and primary care. Health Soc Care Community 2013; 21: 606-13.
18. Edwards L, Thomas C, Gregory A, Yardley L, O'Cathain A, Montgomery AA, et al. Are people with chronic diseases interested in using telehealth? A cross-sectional postal survey. J Med Internet Res 2014; 16: e123.
19. Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20: 1727-36.
20. Mihalopoulos C, Chen G, Iezzi A, Khan MA, Richardson J. Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures. Br J Psychiatry 2014; 205: 390-7.
21. Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, et al. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess 2014; 18(34).
22. Curtis L. Unit Costs of Health and Social Care 2013. Personal Social Services Research Unit, 2013.
23. Department of Health. Reference Costs 2012/13. Department of Health, 2013.
24. Prescribing and Primary Care Team, Health and Social Care Information Centre. Prescription Cost Analysis: England 2013 (available from http://www.hscic.gov.uk/catalogue/PUB13887). Health and Social Care Information Centre, 2014.
25. ONS. Annual Survey of Hours and Earnings, 2013 Provisional Results. ONS, 2013.
26. Royston P, White IR. Multiple Imputation by Chained Equations (MICE): implementation in Stata. J Stat Softw 2011; 45: 1-20.
27. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011; 30: 377-99.
28. Euroqol. Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Secondary Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets (http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Crosswalk_5L/EQ-5D-5L_Crosswalk_model_and__methodology.pdf).
29. Glick H, Doshi J, Sonnad S, Polsky D. Economic Evaluation in Clinical Trials. Oxford University Press, 2007.
30. Faria R, Gomes M, Epstein D, White I. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharma-coeconomics 2014; 32: 1157-70.
31. Rubin DB. Introduction. Multiple Imputation for Nonresponse in Surveys: 1-26. Wiley, 1987.
32. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005; 14: 487-96.
33. Drummond M, Sculpher M, Claxton K, Stoddart G, Torrance G. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford University Press, 2015.
34. Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeco-nomics 2000; 17: 479-500.
35. Gray A, Clarke PM, Wolstenholme JL, et al. Applied Methods of Cost-effectiveness Analysis in Healthcare. Oxford University Press, 2010.
36. Williams C. Overcoming Depression and Low Mood: A Five Areas Approach. 3rd ed. Hodder Arnold, 2009.
37. Mistry H, Garnvwa H, Oppong R. Critical appraisal of published systematic reviews assessing the cost-effectiveness of telemedicine studies. Telemed J E Health 2014; 20: 609-18.
38. Donker T, Blankers M, Hedman E, Ljotsson B, Petrie K, Christensen H. Economic evaluations of Internet interventions for mental health: a systematic review. Psychol Med 2015; 45: 3357-76.
39. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ 2013; 346: f1049.
40. Green C, Richards DA, Hill JJ, Gask L, Lovell K, Chew-Graham C, et al. Cost-effectiveness of collaborative care for depression in UK primary care: economic evaluation of a randomised controlled trial (CADET). PLoS One 2014; 9: e104225.
41. Richards DA, Hill JJ, Gask L, Lovell K, Chew-Graham C, Bower P, et al. Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ 2013; 347: f4913.
42. Brilleman SL, Metcalfe C, Peters TJ, Hollingworth W. The reporting of treatment nonadherence and its associated impact on economic evaluations conducted alongside randomized trials: a systematic review. Value Health 2016; 19: 99-108.